BioTek Instruments, Inc., announced the release of Gen5™ Microplate Data Collection and Analysis Software. The release of Gen5 marks the culmination of an intensive development activity, bringing to the market the first all-new software for microplate data analysis in several years.
Designed for the unique requirements and preferences of microplate instrumentation users, Gen5 offers a clean, uncluttered interface with multiple options for access to the most common tasks. Gen5 includes StepWise™ tools that provide ease of use with truly intuitive procedure creation for basic to very complicated protocols. The data analysis capability is powerful and flexible, yet easily defined. Gen5 will serve as the operating system for all BioTek Instruments, Inc.’s automated detection systems. Several versions of Gen5 are available, including Gen5 Secure with features for compliance to 21 CFR Part 11.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. The BioTek Instruments, Inc. instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.
Company websiteBioTek Instruments, Inc.